» Articles » PMID: 37009634

Potency-Enhancing Synthetics in the Drug Overdose Epidemic: Xylazine ("Tranq"), Fentanyl, Methamphetamine, and the Displacement of Heroin in Philadelphia and Tijuana

Overview
Date 2023 Apr 3
PMID 37009634
Authors
Affiliations
Soon will be listed here.
Abstract

Multiple transformations-referred to as "waves" in a panoply of recent public health and law enforcement publications-have rendered North American drug markets increasingly toxic since the early 2010s. The introduction of exceptionally potent synthetic sedatives and stimulants is initiating a new generation of drug injectors into co-use of opioids and methamphetamine, catapulting rates of deadly overdoses and infectious diseases. Drawing on extensive participant-observation research in Philadelphia (2007-present) and Tijuana (2018-present), we document the experience of street-based drug users across these two North American cities to focus on regional shifts in narcotics supplies and endpoint user preferences. We link the dramatic proliferation of fentanyl, methamphetamine, xylazine, and Mexican white powder heroin to: 1) pre-existing drug supply networks on the western and eastern coasts of the North American subcontinent; 2) material characteristics of local heroin supplies in pre-fentanyl opiate markets (Mexican black tar vs. Colombian off-white powder heroin); and 3) racialized repression/incarceration of drug sellers and users on both sides of the Mexico-US border. The article combines economic and medical anthropology to develop an ethnographically-informed political economy approach to an urgent public health challenge among street-based drug users with the highest overdose mortality rates in the US Northeastern Rust Belt and the Northwestern Mexican borderland metroplex anchored by Tijuana. It foregrounds street users' experiences in real time amidst rapidly shifting narcotics supply chains, linking market-driven logics of profit-seeking to the war on drugs' prohibitionist policy context, highlighting increasing toxic impacts on vulnerable sectors across regions.

Citing Articles

The resurgence of synthetic cannabinoid receptor agonists as adulterants in the Era of Cannabis legalization: Lessons from prior epidemics and clinical implications.

Jones A, Marwan Abu Taha A, Miller G Neurosci Biobehav Rev. 2025; 170:106043.

PMID: 39922438 PMC: 11870277. DOI: 10.1016/j.neubiorev.2025.106043.


The Rise of Fentanyl: Molecular Aspects and Forensic Investigations.

Barletta C, Di Natale V, Esposito M, Chisari M, Cocimano G, Di Mauro L Int J Mol Sci. 2025; 26(2).

PMID: 39859160 PMC: 11765396. DOI: 10.3390/ijms26020444.


Decrease in injection and rise in smoking and snorting of heroin and synthetic opioids, 2000-2021.

Karandinos G, Unick J, Ondocsin J, Holm N, Mars S, Montero F Drug Alcohol Depend. 2024; 263:111419.

PMID: 39216201 PMC: 11684856. DOI: 10.1016/j.drugalcdep.2024.111419.


Xylazine is an agonist at kappa opioid receptors and exhibits sex-specific responses to opioid antagonism.

Bedard M, Huang X, Murray J, Nowlan A, Conley S, Mott S Addict Neurosci. 2024; 11.

PMID: 39086495 PMC: 11290297. DOI: 10.1016/j.addicn.2024.100155.


Illicit Fentanyl Use and Hepatitis C Virus Seroconversion Among People Who Inject Drugs in Tijuana and San Diego: Results From a Binational Cohort Study.

Friedman J, Abramovitz D, Skaathun B, Rangel G, Harvey-Vera A, Vera C Clin Infect Dis. 2024; 79(4):1109-1116.

PMID: 39078273 PMC: 11478577. DOI: 10.1093/cid/ciae372.


References
1.
Bluthenthal R, Wenger L, Chu D, Bourgois P, Kral A . Drug use generations and patterns of injection drug use: Birth cohort differences among people who inject drugs in Los Angeles and San Francisco, California. Drug Alcohol Depend. 2017; 175:210-218. PMC: 5494991. DOI: 10.1016/j.drugalcdep.2017.04.001. View

2.
Beletsky L, Davis C . Today's fentanyl crisis: Prohibition's Iron Law, revisited. Int J Drug Policy. 2017; 46:156-159. DOI: 10.1016/j.drugpo.2017.05.050. View

3.
Reed M, Imperato N, Bowles J, Salcedo V, Guth A, Rising K . Perspectives of people in Philadelphia who use fentanyl/heroin adulterated with the animal tranquilizer xylazine; Making a case for xylazine test strips. Drug Alcohol Depend Rep. 2023; 4:100074. PMC: 9949306. DOI: 10.1016/j.dadr.2022.100074. View

4.
Clarke S, Kral A, Zibbell J . Consuming illicit opioids during a drug overdose epidemic: Illicit fentanyls, drug discernment, and the radical transformation of the illicit opioid market. Int J Drug Policy. 2021; 99:103467. PMC: 8755588. DOI: 10.1016/j.drugpo.2021.103467. View

5.
Strickland J, Havens J, Stoops W . A nationally representative analysis of "twin epidemics": Rising rates of methamphetamine use among persons who use opioids. Drug Alcohol Depend. 2019; 204:107592. PMC: 6884137. DOI: 10.1016/j.drugalcdep.2019.107592. View